Rialto Wealth Management LLC Buys Shares of 149 Danaher Co. (NYSE:DHR)

Rialto Wealth Management LLC purchased a new position in Danaher Co. (NYSE:DHR) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 149 shares of the conglomerate’s stock, valued at approximately $34,000.

Other large investors have also made changes to their positions in the company. Kentucky Retirement Systems Insurance Trust Fund grew its stake in Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock worth $4,874,000 after buying an additional 2,202 shares during the last quarter. ORG Partners LLC raised its stake in Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after buying an additional 2,559 shares during the last quarter. Generate Investment Management Ltd acquired a new stake in Danaher in the fourth quarter worth about $8,044,000. Stifel Financial Corp grew its stake in shares of Danaher by 1.3% during the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock worth $235,583,000 after acquiring an additional 11,216 shares during the last quarter. Finally, Compass Capital Management Inc. increased its holdings in shares of Danaher by 4.8% during the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate’s stock valued at $54,615,000 after acquiring an additional 10,994 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 11.10% of the stock is owned by corporate insiders.

Danaher Stock Down 1.1 %

DHR stock opened at $212.35 on Monday. The firm’s fifty day moving average is $222.51 and its 200 day moving average is $242.62. The firm has a market cap of $151.77 billion, a PE ratio of 40.22, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a one year low of $196.80 and a one year high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the firm posted $2.09 earnings per share. On average, research analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.32 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.60%. Danaher’s dividend payout ratio (DPR) is 24.24%.

Wall Street Analyst Weigh In

DHR has been the subject of a number of recent analyst reports. Scotiabank initiated coverage on shares of Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price on the stock. Raymond James reiterated a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. JPMorgan Chase & Co. cut their target price on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a research report on Friday, December 13th. Finally, Barclays cut their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.